FEDERAL REPUBLIC OF NIGERIA AFRICA HERBAL ANTIMALARIAL MEETING PRESENTATION BY HASHIM UBALE YUSUFU NAFDAC – NIGERIA 20 – 22 MARCH 2006 NAIROBI KENYA.

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Session 6 : Need for good governance Importance of veterinary legislation and its appropriate implementation Jean-Luc ANGOT, CVO, France 14 March 2013.
Personal Finance Product Labels. Food Products Required Information by the FDA Common name Form of food (whole, chopped, diced, etc) Net weight or volume.
BACKGROUND: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh,
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
Federal agency for medicines and health products EXCIPIENTS IN THE LABLE AND PACKAGE LEAFLET OF HOMEOPATHIC MEDICINAL PRODUCTS Patricia Bodart – 23 October.
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Pharmacy Compounding Legislation and Implementation AFDO 118th Annual Educational Conference Susan Laska Deputy Director Office of Medical Products & Tobacco.
Evaluation of quality and interchangeability of medicinal products Training workshop for evaluators from National Medicines Regulatory Authorities in East.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
AND GENERIC DRUGS BRAND-NAME AND GENERIC DRUGS WHAT TO CHOOSE? Natalia VEZIKOVA, MD, PhD, Natalia VEZIKOVA, MD, PhD, MSc The Head of the Hospital Therapy.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
WHO Traditional Medicine Strategy and Guidelines Dr Arvind Mathur MD, DHA, DNB Cluster Coordinator Family & Community Health WHO-India World Health Organisation.
Traditional & Complementary Medicine in Malaysia [International Conclave on Traditional Medicine, New Delhi, INDIA Nov. 2006] Datuk Dr. M.S. Pillay.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
The South African perspective
Impact Health NDAC Meeting Stewart Levy R.Ph. January 14, 2005.
CHAPTER 5 DRUGS, BIOLOGICALS, MEDICAL EQUIPMENT AND INFRASTRUCTURE Ts. Nguyễn Thị Kim Chúc.
Ornanong Mahakkapong Senior Researcher 18 May 2015
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
NRA in BTSs of the EMR Dr. Nabila E. Metwalli Regional Advisor / Blood Safety WHO / EMRO Cairo, Egypt and Dr. Abdel Aziz Saleh WHO / EMRO Advisor.
ACCESS TO MEDICINES - POLICY AND ISSUES
TECHNICAL REQUIREMENTS FOR MINOR APPLICATIONS E MOKANTLA 3 SEPTEMBER 2013.
Licensing conditions of realisation economic activities of manufacture, wholesale and retail trade in medical products.
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
“Grassroots Leverage” In partnership with
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
CHAPTER V Health Information. Updates on new legislation (1)  Decision No.1605/2010/QĐ-TTg approving the National Program for Application of information.
History of Pediatric Labeling
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Dr. Pen Sunna National Centre of Traditional Medicine, Ministry of Health.
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
27 June 2000Victor F. C. Raczkowski, M.D.1 Risk-Management Options Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June.
Veterinary Products Management and Quality Control System in Thailand : Veterinary Vaccine Tasanee Lorchaivej Workshop on the Veterinary Products.
Link between legal framework of VMP regulation and VICH GLs in Japan Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Clinical Trials.
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
Detection & monitoring of ADR
FDA’s IDE Decisions and Communications
Sudan National Experience in TCM
A-z sme export workshop victoria island lagos
GMP Inspection Process
FEDERAL REPUBLIC OF NIGERIA
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Using Medicines Safely (2:50)
Opening an IND: Investigator Perspective
Dr Manisha Shridhar Regional Advisor WHO-SEARO
EU Food Safety Requirements: - Hygiene of Foodstuffs -
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
‘Data ethics and bio-banking’
PHARMACOVIGILANCE SYSTEM
Interconnection of good practices: from development to distribution
NIGERIAN REGISTRATION SYSTEMS OF VETERINARY MEDICINAL PRODUCTS :
Presentation transcript:

FEDERAL REPUBLIC OF NIGERIA

AFRICA HERBAL ANTIMALARIAL MEETING PRESENTATION BY HASHIM UBALE YUSUFU NAFDAC – NIGERIA 20 – 22 MARCH 2006 NAIROBI KENYA.

ABOUT NIGERIA Population over 130 million people −Growing at about 3%/annum −Most populous nation in Africa  Several languages/dialects and cultures −English official language

Nigeria’s Healthcare System  Primary  LGA responsibility  Oversees  Health posts, health clinics, health centers  Community health worker  Secondary  State responsibility.  Oversees  General and Cottage hospitals (One in each of 774 LGAs.  Other secondary health care providers  Tertiary  Largely Federal responsibility  Teaching and specialist hospitals −At least one in each of 36 states and FCT  Few private hospitals with limited but highly specialized services

HISTORY. The use of herbal medicines' in Nigeria dates back to the earliest history of mankind, as in other cultures worldwide. People have relied totally on traditional remedies for all their healthcare needs. They use herbs, animal or mineral based medicines often laced with spiritual ingredients such as incantations.

It is a source of livelihood for a significant number of our population. 1.The closest to the people. 2.High cost of allopathic medicines have encouraged demand. 3.Lack of adequate primary healthcare have made people resort to TMPs for their immediate treatment. As the population increases, demand for traditional medicine will increase.

Manufacture Importation Exportation Distribution Advertisement Sale Use Foods Drugs Cosmetics Chemicals and Detergents Medical Devices All Packaged Drinks OF NAFDAC MANDATE To Control and Regulate the:

PROBLEMS WITH EARLY REGULATION OF HERBAL PRODUTCS. Very little attention from Government. Resistance and lack of co-operation of practitioners due to lack of trust of government intentions. Insecurity due to fear of loss of traditional knowledge.

STRATEGIES undertaken for successful implementation of regulation and control of herbal medicines: Organized a workshop on Standardization and Regulation of Herbal Medicines (1997) in collaboration with BDPC and WAPF. Consultative meeting with NIPRD, to develop draft regulations and guidelines. Review of the draft guidelines by committee of experts leading to categorized protocol for listing/registration of traditional/herbal medicines. In line with WHO recommendation of accepting herbal products based on long history of safe use in a locality, decided to use acute toxicity tests as safety parameter for simple herbal preparations. Efficacy tests, detailed analysis and clinical trials for drugs for complex diseases such as Hepatitis, HIV/AIDS etc.

GUIDELINES FOR REGISTRATION/ LISTING OF HERBAL MEDICINES AND RELATED PRODUCTS GENERAL RULES Herbal medicinal products to be considered for registration or listing were categorized as: –Herbal medicinal products manufactured locally. –Imported Herbal medicinal products. –Homeopathic herbal medicinal products.

APPLICATION. 1.Applicants shall obtain an application form upon payment of prescribed fees. 2.The applicants/manufacturers shall submit completed application forms with relevant documents vis: - Receipt of purchase of application form. Certificate of Registration of Business. An acceptable certificate of analysis testifying that the medicine is of proven quality and safety from accredited centers recognized by NAFDAC. Appropriate Dossier Format (containing method of analysis or assay of the medicine, stability data etc) for product to get registered /listed. Any other relevant documents.

Pre-registration inspection shall be carried out on the production premises by NAFDAC Inspectors after payment of prescribed fees to assess Good Manufacturing Practice (GMP) standards If inspection is satisfactory, NAFDAC inspectors will collect samples for Laboratory analysis. All herbal medicinal products must be adequately labeled before samples are sent to the laboratory.

On receipt of satisfactory laboratory report, the product is approved for listing. For full registration, satisfactory report of local clinical trials will be required. *Note that listing is for two (2) years period while registration is for (5) years. All applicants/manufacturers shall pay the prescribed fee for registration/listing Certificate after approval. Applicants/manufacturers shall submit mandatory post marketing surveillance report on the use and adverse reactions of the herbal medicinal products periodically.

IMPORTED HERBAL MEDICINAL PRODUCTS In addition to General rules, the following documents are required for imported herbal medicinal products. –Power of Attorney issued by the manufacturer and notarized by a notary public from the Country of Origin. –Certificate of pharmaceutical production (COPP). –Application for permit to import samples for registration/listing purpose. –Evidence of satisfactory clinical trials conducted in the Country of origin as appropriate. –Any other relevant information on the products

OTHER REQUIREMENTS INCLUDE: Applicants shall submit dossiers containing relevant information on the products format. Oversea GMP INSPECTION will be carried out on the premises of the manufacturer of herbal medicinal products. A mandatory local clinical Trial in an approval Institution to be funded by the applicants /manufacturers must be carried out for full registration. On receipt of satisfactory laboratory reports, the products may be approved for registration/ listing. Applicants shall also pay a prescribed fee for registration /listing Certificate after approval.

LABELLING REQUIREMENTS The herbal medicinal preparations manufactured locally or imported to Nigeria shall carry the following basic labeling information in English and may include other languages. Name of the product (Not suggestive of therapeutic claim). Generic name if applicable. Quantitative list of Ingredients by their Botanical or common names. Dosage for and Net contents in terms of weight/measure count.

Directions for use Indications (shall be on the leaflet). No claim of cure is permitted until proven through clinical trial. Also subject to advertisement regulations. Batch number. Manufacturing date Expiry date Special storage conditions. Name and full location address of manufacturer. Provision for NAFDAC registration number.

Dosage Mode of administration. Duration of use (e.g. specify if expected response is not felt within a certain number of days consult your doctor) Specific symptoms of overdose and antidote on the leaflet Contra-indications/drug interactions Warnings, if any. Precautions. (E.g. use in pregnant and lactating mothers not recommended).

PROMOTION OF TMP Public Enlightenment Campaigns throughout the country Developed a Standard Pharmacognosy Laboratory Conducted international and local trainings to build capacity. Sponsored the TMP to build strong associations. Supported Research Institutions and Universities.

CONTROL OF ADVERTISEMENT: Conducted a workshop to educate the media on the dangers of advertising the claims of HMPs which have not been substantiated. Media houses were warned that advertisement without clearance from NAFDAC will be sanctioned. Called on the NBC to support us in the crusade. The Director General also advocated to the State Governors to stop State Media houses from advertising the unapproved claims of herbal medical practitioners.

PUBLIC AWARENESS CAMPAIGNS

CONCLUSION NAFDAC has put in place appropriate mechanisms for the regulation and control of Herbal Medicines. We have encouraged practitioners to come out and market their products without much fear. The Agency is building strong collaboration between the Ministry of health, Research Institutes, Universities and the Practitioners.

THANK YOU

26 FEDERAL REPUBLIC OF NIGERIA Website: CONTACT PHONE NUMBERS ABUJA: LAGOS: GSM: OR